Midazolam in modern anesthesiology and intensive care

I Lisnyy; K Zakalska

doi:10.31636/pmjua.v10i3-4.1

Автор(и)

I Lisnyy Nonprofit Organization «National Cancer Institute», Kyiv, Ukraine
K Zakalska Nonprofit Organization «National Cancer Institute», Kyiv, Ukraine

DOI:

https://doi.org/10.31636/pmjua.v10i3-4.1

Ключові слова:

мідазолам, седація, інтенсивна терапія, бензодіазепіни

Анотація

Статтю присвячено вивченню можливостей використання мідазоламу в анестезіологічній практиці. Цей бензодіазепіновий гіпнотик короткої дії може посилювати знеболювальну дію інших анестетиків, але сам по собі не володіє таким ефектом. Перевагою цього препарату є його мінімальний вплив на серцево-судинну систему. Показано, що мідазолам є одним із найчастіше використовуваних седативних засобів під час діагностичних інвазивних процедур, а також у відділеннях інтенсивної терапії.

Завантаження

Дані завантаження ще не доступні.

Посилання

1. Chen, L., Zhang, J., He, W., & Liu, W. (2021). Comparative Effects of Dexmedetomidine and Midazolam on Dreaming of Patients Undergoing Flexible Bronchoscopy During General Anesthesia. Medical Science Monitor, 2(27), e929000. doi: 10.12659/MSM.929000

2. Smith, M.T., Eadie, M.J., & Brophy, T.O. (1981). The pharmacokinetics of midazolam in man. European Journal of Clinical Pharmacology, 19, 271–8 . doi:10.1007/BF00562804.

3. Aitkenhead, A.R., Pepperman, M.L., Willatts, S.M., Coates, P.D., Park, G.R., Bodenham, A.R., …Wallace, P.G. (1989). Comparison of propofol and midazolam for sedation in critically ill patients. Lancet, 2 (8665), 704–9.

4. Shapiro, J.M., Westphal, L.M., White, P.F., Sladen R.N., & Rosenthal, M.H. (1986). Midazolam infusion for sedation in the intensive care unit: effect on adrenal function. Anesthesiology, 64, 394–8. doi:10.1097/00000542–198603000–00022.

5. Greenblatt, D.J., Abernethy, D.R., Locniskar, A., Harmatz, J.S., Limjuco, R.A., & Shader R.I. (1984). Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology, 61(1), 27–35.

6. Reves, J.G., Fragen, R.J., Vinik, H.R., & Greenblatt, D.J. (1985). Midazolam: pharmacology and uses. Anesthesiology, 62, 310–24.

7. Amrein, R., & Hetzel, W. (1994). Pharmacology of Dormicum (midazolam) and Anexate (flumazenil). Acta Anaesthesiologica Scandinavica, 92, 6–15.

8. Ziegler, W.H., Schalch, E., Leishman, B., & Eckert, M. (1983). Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites. British Journal of Clinical Pharmacology, 16 Suppl. 1, 63–69. doi:10.1111/j.1365–2125.1983.tb02272.x.

9. Bauer, T.M., Ritz, R., Haberthur, C., Ha, H.R., Hunkeler, W., Sleight, A.J., … Haefeli, W.E. (1995). Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet, 346(8968), 145–7. doi:10.1016/s0140–6736(95)91209–6.

10. Power, В.M., Forbes, A.M., van Heerden, P.V., & Ilett, K.T. (1998). Pharmacokinetics of Drugs Used in Critically Ill Adults. Clinical Pharmacokinetics, 34 (1), 25–56. doi:10.2165/00003088–199834010–00002.

11. Mandema, J.W., Tuk, B., van Steveninck, A.L., Breimer, D.D., Cohen, A.F., & Danhof, M. (1992). Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clinical Pharmacology & Therapeutics, 51(6), 715–28. doi:10.1038/clpt.1992.84.

12. Lauven, P.M., Schwilden, H., Stoeckel, H., & Greenblatt D.J. (1985). The effects of a benzodiazepine antagonist Ro 15–1788 in the presence of stable concentrations of midazolam. Anesthesiology, 63(1), 61–4. doi:10.1097/00000542–198507000–00009.

13. Kanto, J., Aaltonen, L., Himberg, J.J., & Hovi-Viander M. (1986). Midazolam as an intravenous induction agent in the elderly: a clinical and pharmacokinetic study. Anesthesia & Analgesia, 65(1), 15–20.

14. Halliday, N.J., Dundee, J.W., Collier, P.S., Loughran, P.G., & Harper K.W. (1985). Influence of plasma proteins on the onset of hypnotic action of intravenous midazolam. Anaesthesia, 40(8), 763–6. doi: 10.1111/j.1365–2044.1985.tb11001.x.

15. Harper, K.W., Collier, P.S., Dundee, J.W., Elliott, P., Halliday, N.G., & Lowry, K.G. (1985). Age and nature of operation influence the pharmacokinetics of midazolam. British Journal of Anaesthesia, 57(9), 866–71. doi: 10.1093/bja/57.9.866.

16. Vinik, H.R., Reves, J.G., Greenblatt, D.J., Abernethy, D.R., & Smith, L.R. (1983). The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology, 59(5), 390–4. doi: 10.1097/00000542–198311000–00005.

17. MacGilchrist, A.J., Birnie, G.G., Cook, A., Scobie, G., Murray, T., Watkinson, G., & Brodie, M.G. (1986). Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut, 27(2), 190–5. doi: 10.1136/gut.27.2.190.

18. Shafer, A., Doze, V.A., & White, P.F. (1990). Pharmacokinetic variability of midazolam infusions in critically ill patients. Critical Care Medicine, 18(9), 1039–41. doi: 10.1097/00003246–199009000–00024.

19. Michalk, S., Moncorge, C., Fichelle, A., Huot, O., Servin, F., Farinotti, R., & Desmonts, J.M. (1988). Midazolam infusion for basal sedation in intensive care: absence of accumulation. Intensive Care Medicine, 15(1), 37–41. doi: 10.1007/BF00255634.

20. Byrne, A., Yeoman, P.M., & Mace, P. (1984). Accumulation of midazolam in patients receiving mechanical ventilation [letter]. BMJ, 289(6454), 1309. doi: 10.1136/bmj.289.6454.1309.

21. Malacrida, R., Fritz, M.E., Suter, P.M., & Crevoisieret, C. (1992). Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Critical Care Medicine, 20(8), 1123–6. doi: 10.1097/00003246–199208000–00010.

22. Driessen, J.J., Vree, T.B., & Guelen, P.J. (1991). The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients. Acta Anaesthesiologica Belgica , 42(3), 149–55.

23. Maitre, P.O., Funk, B., Crevoisier, C., & Ha, H.R. (1989). Pharmacokinetics of midazolam in patients recovering from cardiac surgery. European Journal of Clinical Pharmacology, 37(2), 161–6. doi: 10.1007/BF00558225.

24. Shelly, M.P., Mendel, L., & Park, G.R. (1987). Failure of critically ill patients to metabolise midazolam. Anaesthesia, 42(6), 619–26. doi: 10.1111/j.1365–2044.1987.tb03086.x.

25. Park, G.R., Miller, E., & Navapurkar, V. (1996). What changes drug metabolism in critically ill patients. II: serum inhibits the metabolism of midazolam in human hepatocytes. Anaesthesia, 51(1), 11–5. doi: 10.1111/j.1365–2044.1996.tb07646.x.

26. Muller, C.M., Scierka, A., Stiller, R.L., Kim, Y.M., Cook, D.R., Lancaster, J.R., … Watkins, W.D. (1996). Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin. Anesthesiology, 84(6), 1435–42. doi: 10.1097/00000542–199606000–00020.

27. Park, G.R., & Miller, E. (1996). What changes drug metabolism in critically ill patients. III: effect of preexisting disease on the metaboism of midazolam. Anaesthesia, 51(5), 431–4. doi: 10.1111/j.1365–2044.1996.tb07785.x.

28. McConachie, I., & McGeachie, J. (1995). Regional Anaesthetic Techniques. In: Healy TEJ, Cohen PJ, eds. Wylie and Churchill-Davidson’s A Practice of Anaesthesia. 6th ed. London: Edward Arnold, 708–734.

29. Malacrida, R., Fritz, M.E., Suter, P.M., & Crevoisier, C. (1992). Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Critical Care Medicine, 20(8), 1123–6. doi: 10.1097/00003246–199208000–00010.

30. Ernest, D., & Cutler, D.J. (1992). Gentamicin clearance during continuous arteriovenous hemodiafiltration. Critical Care Medicine, 20(5), 586–9. doi: 10.1097/00003246–199205000–00007.

31. Maitre, P.O., Funk, B., Crevoisier, C., & Ha, H.R. (1989). Pharmacokinetics of midazolam in patients recovering from cardiac surgery. European Journal of Clinical Pharmacology, 37(2), 161–6. doi: 10.1007/BF00558225.

32. Flores-Pérez, C., Flores-Pérez, J., Moreno-Rocha, L.A., Chávez-Pacheco, J.L., Noguez-Mendez, N.A., Ramirez-Mendiola, B., … Sarmiento-Arguello, L. (2023). Influence of Age and Sex on the Pharmacokinetics of Midazolam and the Depth of Sedation in Pediatric Patients Undergoing Minor Surgeries. Pharmaceutics, 15(2), 440. doi: 10.3390/pharmaceutics15020440.

33. Harper, K.W., Collier, P.S., Dundee, J.W., Elliott, P., Halliday, N.J., & Lowry, K.G. (1985). Age and Nature of Operation Influence the Pharmacokinetics of Midazolam. British Journal of Anaesthesia, 57(9), 866–871. doi: 10.1093/bja/57.9.866.

34. Park, J.Y., Kim, B.J., Lee, S.W., Kang, H., Kim, J.W., Jang, I.J., & Kim, J.G. (2019). Influence of Midazolam-Related Genetic Polymorphism on Conscious Sedation during Upper Gastrointestinal Endoscopy in a Korean Population. Scientific Reports, 9(1), 16001. doi: 10.1038/s41598–019–52517–7.

35. Johnson, T.N., Rostami-Hodjegan, A., Goddard, J.M., Tanner, M.S., & Tucker, G.T. (2002). Contribution of Midazolam and Its 1-Hydroxy Metabolite to Preoperative Sedation in Children: A Pharmacokinetic-Pharmacodynamic Analysis. British Journal of Anaesthesia, 89(3), 428–37.

36. Dundee, J.W., Halliday, N.J., Harper, K.W., & Brogden, R.N. (1984). Midazolam: A Review of Its Pharmacological Properties and Therapeutic Use. Drugs, 28(6), 519–43. doi: 10.2165/00003495–198428060–00002.

37. Marçon, F., Guittet, C., Manso, M.A., Burton, I., Granier, L.A., Jacqmin, P., & Dupont, H. (2018). Population Pharmacokinetic Evaluation of ADV6209, an Innovative Oral Solution of Midazolam Containing Cyclodextrin. European Journal of Pharmaceutical Sciences, 114, 46–54. doi: 10.1016/j.ejps.2017.11.030.

38. Sagarin, M.J., Chiang, V., Sakles, J.C., Barton, E.D., Wolfe, R.E., Vissers, R.J., & Walls, R.M. (2002). Rapid Sequence Intubation for Pediatric Emergency Airway Management. Pediatric Emergency Care, 18(6), 417–423. doi: 10.1097/00006565–200212000–00004.

39. Woolsey, S.J., Beaton, M.D., Choi, Y.H., Dresser, G.K., Gryn, S.E., Kim, R.B., & Tirona, R.G. (2016). Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single-Time-Point Oral Midazolam Microdose Phenotype in Healthy Subjects. Basic & Clinical Pharmacology & Toxicology, 118(4), 284–91. doi: 10.1111/bcpt.12492.

40. Liu, J-Y., Guo, F., Wu, H-L., Wang, Y., & Liu, J-S. (2017). Midazolam anesthesia protects neuronal cells from oxidative stress-induced death via activation of the JNK-ERK pathway. Molecular Medicine Reports, 15(1), 169–179. doi: 10.3892/mmr.2016.6031.

41. Briner, A., De Roo, M., Dayer, A., Muller, D., Habre, W., & Vutskits, L. (2010). Volatile anesthetics rapidly increase dendritic spine density in the rat medial prefrontal cortex during synaptogenesis. Anesthesiology, 112(3), 546–56. doi: 10.1097/ALN.0b013e3181cd7942.

42. Jevtovic-Todorovic, V., Hartman, R.E., Izumi, Y., Benshoff, N.D., Dikranian, K., Zorumski, C.F., … Wozniak, D.F. (2003). Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. Journal of Neuroscience, 23(3), 876–82. doi: 10.1523/JNEUROSCI.23–03–00876.2003.

43. Vutskits, L., Gascon, E., Tassonyi, E., & Kiss, J.Z. (2005). Clinically relevant concentrations of propofol but not midazolam alter in vitro dendritic development of isolated gamma-aminobutyric acid-positive interneurons. Anesthesiology, 102(5), 970–6. doi: 10.1097/00000542–200505000–00016.

44. Mishra, S.K., Kang, J.H., Lee, C.W., Oh, S.H., Ryu, J.S., Bae, Y.S., & Kim, H.M. (2013). Midazolam induces cellular apoptosis in human cancer cells and inhibits tumor growth in xenograft mice. Molecular Cell, 36(3), 219–26. doi: 10.1007/s10059–013–0050–9.

45. Stevens, M.F., Werdehausen, R., Gaza, N., Hermanns, H., Kremer, D., Bauer, I., … Braun, S. (2011). Midazolam activates the intrinsic pathway of apoptosis independent of benzodiazepine and death receptor signaling. Regional Anesthesia & Pain Medicine, 36(4), 343–9. doi: 10.1097/AAP.0b013e318217a6c7.

46. Goneppanavar, U., Magazine, R., Periyadka, J.B., & Krishna, A. S. (2015). Intravenous dexmedetomidine provides superior patient comfort and tolerance compared to intravenous midazolam in patients undergoing flexible bronchoscopy. Pulmonary Medicine, 727530. doi: 10.1155/2015/727530.

47. Leslie, K., Skrzypek H., Paech M.J., Kurowski, I. & Whybrow, T. (2007). Dreaming during anesthesia and anesthetic depth in elective surgery patients: A prospective cohort study. Anesthesiology, 106(1), 33–42. doi: 10.1097/00000542–200701000–00010.

48. Kain, Z.N., & Caldwell-Andrews, A.A. (2003). Sleeping characteristics of adults undergoing outpatient elective surgery: a cohort study. Journal of Clinical Anesthesiology, 15(7),505–9. doi: 10.1016/j.jclinane.2003.02.002.

49. Chouchou, F., Khoury, S., Chauny, J.M., Denis, R., & Lavigne, G.J. (2014). Postoperative sleep disruptions: a potential catalyst of acute pain? Sleep Medicine Reviews, 18(3), 273–82. doi: 10.1016/j.smrv.2013.07.002.

50. Knill, R.L., Moote, C.A., Skinner, M.I., & Rose, E.A. (1990). Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week. Anesthesiology, 73(1), 52–61. doi: 10.1097/00000542–199007000–00009.

51. Gögenur, I., Wildschiøtz, G., & Rosenberg, J. (2008). Circadian distribution of sleep phases after major abdominal surgery. British Journal of Anaesthesia, 100(1), 45–9. doi: 10.1093/bja/aem340.

52. Krenk, L., Jennum, P., & Kehlet, H. (2012). Sleep disturbances after fast-track hip and knee arthroplasty. British Journal of Anaesthesia, 109(5), 769–75. doi: 10.1093/bja/aes252.

53. Rosenberg-Adamsen, S., Skarbye, M., Wildschiødtz, G., Kehlet, H., & Rosenberg, J. (1996). Sleep after laparoscopic cholecystectomy. British Journal of Anaesthesia, 77(5), 572–5. doi: 10.1093/bja/77.5.572.

54. Tan, W., Miao, E., Jin, F., Ma, H., & Lu, H. (2016). Changes in First Postoperative Night Bispectral Index After Daytime Sedation Induced by Dexmedetomidine or Midazolam Under Regional Anesthesia. A Randomized Controlled Trial. Regional Anesthesia & Pain Medicine, 41(3), 380–6. doi: 10.1097/AAP.0000000000000370.

55. Oto, J., Yamamoto, K., Koike, S., Onodera, M., Imanaka, H., & Nishimura, M. (2012). Sleep quality of mechanically ventilated patients sedated with dexmedetomidine. Intensive Care Medicine, 38(12), 1982–9. doi: 10.1007/s00134–012–2685-y.

56. McQuaid, K.R., & Laine, L. (2008). A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointestinal Endoscopy, 67(6), 910–923. doi:10.1016/j.gie.2007.12.046.

57. Cohen, L.B., Wecsler, J.S., Gaetano, J.N., Benson, A.A., Miller, K.M., Durkalski, V., & Aisenberg, J. (2006). Endoscopic sedation in the United States: results from a nationwide survey. American Journal of Gastroenterology, 101(5), 967–74. doi: 10.1111/j.1572–0241.2006.00500.x.

58. Riphaus, A., Rabofski, M., & Wehrmann, T. (2010). Endoscopic sedation and monitoring practice in Germany: results from the first nationwide survey. Z Gastroenterol., 48, 392–397. doi: 10.1055/s-0028–1109765.

59. Thomson, A., Andrew, G., & Jones, D.B. (2010). Optimal sedation for gastrointestinal endoscopy: review and recommendations. Journal of Gastroenterology and Hepatology, 25, 469–478. doi:10.1111/j.1440–1746.2009.06174.x.

60. Meining, A., Semmler, V., Kassem, A.M., Sander, R., Frankenberger, U., Burzin, M., … Schmid, R.M. (2007). The effect of sedation on the quality of upper gastrointestinal endoscopy: an investigator-blinded, randomized study comparing propofol with midazolam. Endoscopy, 39, 345–349. doi:10.1055/s-2006- 945195.

61. Sipe, B.W., Rex, D.K., Latinovich, D., Overley, C., Kinser, K., Bratcher, L., Kareken, D. (2002). Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointestinal Endoscopy, 55, 815–825. doi: 10.1067/mge.2002.124636.

62. Cohen LB. (2008). Patient monitoring during gastrointestinal endoscopy: why, when, and how? Gastrointestinal Endoscopy Clinics of North America, 18, 651–63. doi: 10.1016/ j.giec.2008.06.015.

63. Patel, S., Vargo, J.J., Khandwala, F., Lopez, R., Trolli, P., Dumot, J.A., … Zuccaro G. (2005). Deep sedation occurs frequently during elective endoscopy with meperidine and midazolam. American Journal of Gastroenterology, 100(12), 2689–95. doi: 10.1111/j.1572–0241.2005.00320.x.

64. Dreher, M., Ekkernkamp, E., Storre, J.H., Kabitz, H.J., & Windisch, W. (2010). Sedation during flexible bronchoscopy in patients with preexisting respiratory failure: midazolam versus Midazolam plus Alfentanil. Respiration, 79, 307–14. doi: 10.1159/000267227.

65. Barnett, A.M., Jones, R., & Simpson, G. (2016). A survey of bronchoscopy practice in Australia and New Zealand. Journal of Bronchology & Interventional Pulmonology, 23(1), 22–8. doi: 10.1097/LBR.0000000000000251.

66. Smyth, C.M., & Stead, R.J. (2002). Survey of flexible fibreoptic bronchoscopy in the United Kingdom. European Respiratory Journal, 19(3), 458–63. doi: 10.1183/09031936.02.00103702.

67. Padmanabhan, U., Leslie, K., Eer, A.S., Maruff, P., & Silbert, B.S. (2009). Early Cognitive Impairment After Sedation for Colonoscopy: The Effect of Adding Midazolam and/or Fentanyl to Propofol. Anesthesia & Analgesia, 109(5), 1448–55. doi: 10.1213/ane.0b013e3181a6ad31.

68. Yan, Q., & Sheng, B. (2023). Effect of different doses of midazolam combined with fentanyl during painless bronchoscopy in adults. American Journal of Translational Research, 15(1), 563–572.

69. Wang, M-L., Min, J., Sands, L.P., & Leung, J.M. (2021). Midazolam Premedication Immediately Before Surgery Is Not Associated With Early Postoperative Delirium. Anesthesia & Analgesia, 133(3), 765–771. doi: 10.1213/ANE.0000000000005482.

70. Marcantonio, E.R., Juarez, G., Goldman, L., Mangione, C.M., Ludwig, L.E., Lind, L., … Lee. T.H. (1994). The relationship of postoperative delirium with psychoactive medications. JAMA, 272(19), 1518–22.

71. Albrecht, S., Ihmsen, H., Hering, W., Geisslienger, G., Dingemase, J., Schwilden, H., & Schuttler, J. (1999). The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clinical Pharmacology & Therapeutics, 65(6), 630–9. doi: 10.1016/S0009–9236(99)90084-X.

72. Pastis, N.J., Yarmus, L.B., Schippers, F., Ostroff, R., Chen, A., Akulian, J., … Silvestri, G.A. (2019). Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest, 155(1), 137–146. doi:10.1016/j.chest.2018.09.015

73. Matsumoto, T., Kaneko, A., Fujiki, T., Kusakabe, Y., Noda, A., Tanaka, A., … Mishima, M. (2022). Prevalence and characteristics of disinhibition during bronchoscopy with midazolam. Respiratory Investigation, 60(3), 345–354. doi: 10.1016/j.resinv.2021.11.010.

74. Katsurada, M., Tachihara, M., Katsurada, N., Takata, N., Sato, H., Mimura, C., … Kobayashi, K. (2022). Randomized single-blind comparative study of the midazolam/pethidine combination and midazolam alone during bronchoscopy. BMC Cancer, 22, 539.

75. Magazine, R., Venkatachala, S.K., Goneppanavar, U., Surendra, V.U., Guddattu, V., & Chogtu, B. (2020). Comparison of midazolam and low-dose dexmedetomidine in flexible bronchoscopy: a prospective, randomized, double-blinded study. Indian Journal of Pharmacology, 52(1), 23–30. doi:10.4103/ijp.IJP_287_19.

76. Minami, D., Murakami, E, Shibata, Y., Nakamura, K., Kishino, T., Takigawa, N., … Shibayama, T. (2021). End-tidal capnographic monitoring during flexible bronchoscopy under fentanyl and midazolam sedation. Annals of Palliative Medicine, 10(8), 8665–8671. doi: 10.21037/apm-21–1009.

77. Sumi, T., Kamada, K., Sawai, T., Shijubou, N., Yamada, Y., Nakata, H., … Chiba, H. (2021). Sedation with fentanyl and midazolam without oropharyngeal anesthesia compared with sedation with pethidine and midazolam with oropharyngeal anesthesia in ultrathin bronchoscopy for peripheral lung lesions. Respiratory Investigation, 59(2), 228–234. doi: 10.1016/j.resinv.2020.10.001.

78. Hughes, C.G., McGrane, S., & Pandharipande, P.P. (2012). Sedation in the intensive care setting. Clinical pharmacology: advances and applications, 4, 53–63. doi: 10.2147/CPAA.S26582.

79. Wen, J., Ding, X., Liu, C., Jiang, W., Xu, Y., Wei, X., & Liu. X. (2023).D A comparation of dexmedetomidine and midazolam for sedation in patients with mechanical ventilation in ICU: A systematic review and meta-analysis. PLoS One, 18(11), e0294292. doi: 10.1371/journal.pone.0294292

80. Devlin, J.W., Skrobik, Y., Gelinas, C., Needham, D.M., Slooter, A.J.C., Pandharipande, P.P., … Alhazzani, W. (2018). Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Critical Care Medicine, 46(9), 825–73. doi: 10.1097/CCM.0000000000003299.

81. Young, C.C., & Prielipp, R.C. (2001). Benzodiazepines in the intensive care unit. Critical Care Clinics, 17(4), 843–62. doi: 10.1016/s0749–0704(05)70183–4.

82. Fragen, R.J.(1997). Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. Clinical Therapeutics, 19(3), 405–19, discussion 367–8. doi: 10.1016/s0149–2918(97)80126–9.

83. Milbrandt, E.B., Deppen, S., Harrison, P.L., Shintani, A.K., Speroff, T., Stiles, R.A., … Ely, E.W. (2004). Costs associated with delirium in mechanically ventilated patients. Critical Care Medicine, 32(4), 955–62. doi: 10.1097/01.ccm.0000119429.16055.92.

84. Sanchez, D., Brennan, K., Al Sayfe, M., Shunker, S.A., Bogdanoski, T., Hedges, S., … Frost, S.A. (2020). Frailty, delirium and hospital mortality of older adults admitted to intensive care: the Delirium (Deli) in ICU study. Critical care (London, England), 24(1), 609. doi: 10.1186/s13054–020–03318–2.

85. van den Boogaard, M., Schoonhoven, L., Evers, A.W., van der Hoeven, J.G., van Achterberg, T., & Pickkers, P. (2012). Delirium in critically ill patients: impact on long-term health-related quality of life and cognitive functioning. Critical Care Medicine, 40(1), 112–8. doi: 10.1097/CCM.0b013e31822e9fc9.

86. Salluh, J.I., Wang, H., Schneider, E.B., Nagaraja, N., Yenokyan, G., Damluji, A., … Stevens, R.D. (2015). Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ (Clinical research ed), 350, h2538. doi: 10.1136/bmj.h2538.

87. Wang, M.L., Min, J., Sands, L.P., & Leung, J.M. (2021). Midazolam Premedication Immediately Before Surgery Is Not Associated With Early Postoperative Delirium. Anesthesia & Analgesia, 133(3), 765–71. doi: 10.1213/ANE.0000000000005482.

88. Athanassoglou, V., Cozowicz, C., Zhong, H., Illescas, A., Poeran, J., Liu, J., … Memtsoudis, S.G. (2022). Association of perioperative midazolam use and complications: a population-based analysis. Regional Anesthesia & Pain Medicine, 47 (4), 228–33. doi: 10.1136/rapm-2021–102989.

89. Skrobik, Y., Leger, C., Cossette, M., Michaud, V., & Turgeon, J. (2013). Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflamma- tory factors. Critical Care Medicine, 41(4), 999–1008. doi: 10.1097/CCM.0b013e318275d014.

90. Talke, P., Chen, R., Thomas, B., Aggarwall, A., Gottlieb, A., Thorborg, P., … Kallio, A. (2000). The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesthesia & Analgesia, 90 (4), 834–9. doi: 10.1097/00000539–200004000–00011.

91. Prakash S. (2006). Analgesic Efficacy of Two Doses of Intrathecal Midazolam With Bupivacaine in Patients Undergoing Cesarean Delivery. Regional Anesthesia & Pain Medicine, 31(3), 221–6. doi: 10.1016/j.rapm.2006.02.006.

92. Serrao, J.M., Stubbs, S.C., Goodchild, C.S., & Gent J.P. (1989). Intrathecal midazolam and fentanyl in the rat: Evidence for different spinal antinociceptive effects. Anesthesiology,70(5), 780–6. doi: 10.1097/00000542–198905000–00013.

93. Nishiyama, T., & Hanaoka, K. (2003). Midazolam can potentiate the analgesic effects of intrathecal bupivacaine on acute thermal- or inflammatory-induced pain. Anesthesia & Analgesia, 96(5), 1386–1391. doi: 10.1213/01.ANE.0000057606.82135.7D.

94. Serrao, J.M., Marks, R.L., Morley, S.J., & Goodchild, C.S. (1992). Intrathecal midazolam for the treatment of chronic mechanical low back pain: A controlled comparison with epidural steroid in a pilot study. Pain, 48(1), 5–12. doi: 10.1016/0304–3959(92)90125-U.

95. Batra, Y.K., Jain, K., Chari, P., Dhillon, M.S., Shaheen. B., & Reddy, G.M. (1999). Addition of intrathecal midazolam to bupivacaine produces better postoperative analgesia without prolonging recovery. International Journal of Clinical Pharmacology and Therapeutics, 37(10), 519–23.

96. Valentine, J.M., Lyons, G., & Bellamy, M.C. (1996). The effect of intrathecal midazolam on postoperative pain. European Journal of Anaesthesiology, 13(6), 589–593. doi: 10.1046/j.1365–2346.1996.00044.x.

97. Nishiyama, T., Yokoyama, T., & Hanaoka, K. (1998). Midazolam improves postoperative epidural analgesia with continuous infusion of local anaesthetics. Canadian Journal of Anaesthesia, 45(6), 551–5. doi: 10.1007/BF03012706.

98. Naguib, M., Gammal, M., Elhattab, Y.S., & Seraj, M. (1995). Midazolam for caudal analgesia in children: comparison with caudal bupivacaine. Canadian Journal of Anaesthesia, 42(9), 758–64. doi: 10.1007/BF03011172.

99. Kim, M.H., & Lee, Y.M. (2001). Intrathecal midazolam increases the analgesic effects of spinal blockade with bupivacaine in patients undergoing haemorrhoidectomy. British Journal of Anaesthesia, 86(1), 77–9. doi: 10.1093/bja/86.1.77.

100. Johansen, M.J., Gradert, T.L., Satterfield, W.C., Baze, W.B., Hildebrand, K., Trissel, L., & Hassenbusch, S.J. (2004). Safety of continuous Intrathecal midazolam in the sheep model. Anesthesia & Analgesia, 98(6), 1528–1535. doi.org/10.1213/01.ane.0000120086.35289.9d

101. Bahar, M., Cohen, M.L., Grinshpon, Y., & Chanimov, M. (1998). Spinal anaesthesia with midazolam in the rat. Canadian Journal of Anaesthesia, 44(2), 208–215. doi: 10.1007/BF03013011.

102. Malinowsky, J.M., Cozian, A., Lepage, J.Y., Mussini, J.M., Pinaud, M., & Souron, R. (1991). Ketamine and midazolam neurotoxicity in the rabbit. Anesthesiology, 75(1), 91–7. doi: 10.1097/00000542–199107000–00015.

103. Svensson, B.A., Welin, M., Gordh, T. Jr., & Westman, J. (1995). Chronic subarachnoid midazolam (Dormicum) in the rat; Morphologic evidence of spinal cord neurotoxicity. Regional Anesthesia, 20(5), 426–34.

104. Yaksh, T.L., & Allen, J.W. (2004). Preclinical insights into the implementation of intrathecal midazolam: A cautionary tale. Anesthesia & Analgesia, 98(6), 1509–1511. doi: 10.1213/01.ANE.0000121768.79904.7F.

105. Goodchild, C.S., & Noble, J. (1987). The effects of intrathecal midazolam on sympathetic nervous system reflexes in man: A pilot study. British Journal of Clinical Pharmacology, 23(3), 279–85. doi: 10.1111/j.1365–2125.1987.tb03046.x.

106. Tucker, A.P., Mezzatesta, J., Nadeson, R., & Goodchild, C.S. (2004). Intrathecal midazolam II: Combination with intrathecal fentanyl for labor pain. Anesthesia & Analgesia, 98(6), 1521–1527. doi: 10.1213/01.ANE.0000112434.68702.E4.

107. Bharti, N., Madan, R., Mohanty, P.R., & Kaul, H.L. (2003). Intrathecal midazolam added to bupivacaine improves the duration and quality of spinal anesthesia. Acta Anaesthesiologica Scandinavica, 47(9), 1101–5. doi: 10.1034/j.1399–6576.2003.00186.x.

108. Boussofara, М., Carles, M., Raucoules-Aime, M., Sellam, M.R., & Horn, J-L. (2006). Effects of Intrathecal Midazolam on Postoperative Analgesia When Added to a Bupivacaine-Clonidine Mixture. Regional Anesthesia & Pain Medicine, 31(6), 501–5. doi: 10.1016/j.rapm.2006.05.013.

109. Batra, Y.K., Jain, K., Chari P., Dhillon, M.S., Shaheen, B., & Reddy, G.M. (1999). Addition of intrathecal midazolam to bupivacaine produces better post-operative analgesia without prolonging recovery. International Journal of Clinical Pharmacology and Therapeutics, 37(10), 519–23.

110. Kim, M.H., & Lee, Y.M. (2001). Intrathecal midazolam increases the analgesic effects of spinal blockade with bupivacaine in patients undergoing haemorrhoidectomy. British Journal of Anaesthesia, 86(1), 77–9. doi: 10.1093/bja/86.1.77.

111. Rudomin P. (2002). Selectivity of the central control of sensory information in the mammalian spinal cord. Advances in Experimental Medicine and Biology, 508, 157–170. doi: 10.1007/978–1-4615–0713–0_19.

112. Kohno, T., Wakai, A., Ataka, T., Ikoma, M., Yamakura, T., & Baba, H. (2006). Actions of midazolam on excitatory transmission in dorsal horn neurons of adult rat spinal cord. Anesthesiology, 104(2), 338–43. doi: 10.1097/00000542–200602000–00020.

113. Cox, R.F., & Collins, M.A. (2001). The effects of benzodiazepines on human opioid receptor binding and function. Anesthesia & Analgesia, 93(2), 354–8. doi: 10.1097/00000539–200108000–00024.

114. Nishiyama, T., Matuskawa, T., & Hanoaka K. (1999). Acute phase histopathological study of spinally administered midazolam in cats. Anesthesia & Analgesia, 89(3), 717–20. doi: 10.1097/00000539–199909000–00035.

115. Yegin, A., Sanli, S., Dosemeci, L., Kayacan, N., Akbas, M., & Kasli, B. (2004). The analgesic and sedative effects of intrathecal midazolam in perianal surgery. European Journal of Anaesthesiology, 21(8), 658–62. doi: 10.1017/s0265021504008129.

116. Goodchild, C.S., & Nobel, J. (1987). The effects of intrathecal midazolam on sympathetic nervous system reflexes in man: A pilot study. British Journal of Clinical Pharmacology, 23 (3), 279–285. doi: 10.1111/j.1365–2125.1987.tb03046.x.

117. Tucker, A.P., Lai, C., Nadeson, R., & Goodchild, C.S. (2004). Intrathecal midazolam I: A cohort study investigating safety. Anesthesia & Analgesia, 98(6), 1512–1520. doi: 10.1213/01.ANE.0000087075.14589.F5.

118. O’Boyle, C.A. (1988). Benzodiazepine-Induced amnesia and anaesthetic practice: a review. Psychopharmacology Series, 6, 146–65.

119. Gurunathan, U., Rahman, T,, Williams, Z., Vandeleur, A., Sriram, S., Harch, J., … Royse, C. (2020). Effect of midazolam in addition to propofol and opiate sedation on the quality of recovery after colonoscopy: a randomized clinical trial. Anesthesia & Analgesia, 131(3), 741–750. doi: 10.1213/ANE.0000000000004620.

120. Reinhart, K., Dallinger-Stiller, G., Dennhardt, R., Heinemeyer, G., & Eyrich, K. (1985). Comparison of midazolam, diazepam and placebo i.m. as premedication for regional anaesthesia. A randomized double-blind study. British Journal of Anaesthesia, 57(3), 294–9. doi: 10.1093/bja/57.3.294.

121. Fell, D., Derbyshire, D.R., Maile, C.J., Larsson, I.M., Ellis, R., Achola, K.J., & Smith, G. (1985). Measurement of plasma catecholamine concentrations. British Journal of Anaesthesia, 57(8), 770–4. doi: 10.1093/bja/57.8.770.

122. Olkkola, K.T., & Ahonen, J. (2008). Midazolam and other benzodiazepines. Handbook of Experimental Pharmacology, 182, 335–60. doi: 10.1007/978–3-540–74806–9_16.

123. Memtsoudis, S., Cozowicz, C., & Poeran, J. (2021). Risk factors for postoperative delirium in patients undergoing lower extremity joint arthroplasty: a retrospective population-based cohort study. Regional Anesthesia & Pain Medicine, 46(1), 94–95. doi: 10.1136/rapm-2020–101617.

124. FDA. Fda warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, gralise, horizant) and pregabalin (lyrica, lyrica Cr) when used with CNS depressants or in patients with lung problems. FDA, 2020.

125. Cozowicz, C., Bekeris, J., Poeran, J., Zubizarreta, N., Schwenk, E., Girardi, F., & Memtsoudis, S.G. (2020). Multimodal pain management and postoperative outcomes in lumbar spine fusion surgery: a population-based cohort study. Spine, 45(9), 580–589. doi: 10.1097/BRS.0000000000003320.

126. Athanassoglou, V., Cozowicz, C., Zhong, H., Illescas, A., Poeran, J., Liu, J., … Memtsoudis, S.G. (2022). Association of perioperative midazolam use and complications: a population-based analysis. Regional Anesthesia & Pain Medicine, 47(4), 228–233. doi: 10.1136/rapm-2021–102989.

127. Gonzalez Castro, L.N., Mehta, J.H., Brayanov, J.B., & Mullen, G.J. (2017). Quantification of respiratory depression during pre-operative administration of midazolam using a non-invasive respiratory volume monitor. PLoS One, 12(2), e0172750. doi: 10.1371/journal.pone.0172750.

128. Wang, M-L., Min, J., Sands, L.P., & Leung, G.M. (2021). Midazolam premedication immediately before surgery is not associated with early postoperative delirium. Anesthesia & Analgesia, 133(3), 765–771. doi: 10.1213/ANE.0000000000005482.

129. Hata, A., Yamamoto, M., Iwasaki, M., Morita, T., Ishikawa, M., & Sakamoto, A. (2023). Dexmedetomidine Might Exacerbate Acute Kidney Injury, While Midazolam Might Have a Postconditioning Effect: A Rat Model of Lipopolysaccharide-Induced Acute Kidney Injury. Journal of Nippon Medical School, 90 (5), 387–397. doi: 10.1272/jnms.JNMS.2023_90–406.

130. Gomez, H., & Kellum, J.A. (2016). Sepsis-induced acute kidney injury. Current Opinion in Critical Care, 22(6), 546–553. doi: 10.1097/MCC.0000000000000356.

131. Matsuda, A., Jacob, A., Wu, R., Aziz, M., Yang, W-L., Matsutani, T., … Wang, P. (2012). Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses. Journal of Nippon Medical School, 79(1), 4–18. doi: 10.1272/jnms.79.4.

132. Shehabi, Y., Howe, B.D., Bellomo, R., Arabi, Y.M., Bailey, M., Bass, F.E., … Webb, S.A. (2019). Early sedation with dexmedetomidine in critically ill patients. The New England Journal of Medicine, 380(26), 2506–17. doi: 10.1056/NEJMoa1904710.

133. Plummer, M.P., Lankadeva, Y.R., Finnis, M.E, Harrois, A., Harding, C., Peiris, R.M., … Deane, A.M. (2021). Urinary and renal oxygenation during dexmedetomidine infusion in critically ill adults with mechanistic insights from an ovine model. Journal of Critical Care, 64, 74–81. doi: 10.1016/j.jcrc.2021.03.004.

134. Joo, H.K., Oh, S.C., Cho, E.J., Park, K.S., Lee, J.Y., Lee, E.J., … Jeon, B.H. (2009). Midazolam inhibits tumor necrosis factor-alpha-induced endothelial activation: involvement of the peripheral benzodiazepine receptor. Anesthesiology, 110(1), 106―12. doi: 10.1097/ALN.0b013e318190bc69.

135. Horiguchi, Y., Ohta, N., Yamamoto, S., Koide, M., & Fujino, Y. (2019). Midazolam suppresses the lipopolysaccharide-stimulated immune responses of human macrophages via translocator protein signaling. International Immunopharmacology, 66, 373–82. doi: 10.1016/j.intimp.2018.11.050.